Catalyst Event
Johnson & Johnson (JNJ) · Other
From KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR) (KUSQL500P)
4/16/2026, 12:00:00 AM
Sold the gene-therapy asset botaretigene sparoparvovec (bota-vec) to MeiraGTx on 2026-04-16 as part of a portfolio management strategy. Low importance as the divestiture of a single asset is estimated to have a 1-5% price impact; expected.
Korean Translation
2026년 4월 16일 유전자 치료 자산 보타레티진 스파로파르보벡(보타-벡)을 MeiraGTx에 매각함. 단일 자산 매각은 1-5% 수준의 주가 영향이 예상되어 'Low'로 분류함; 예상됨.
Related Recent Events
Cloudflare Inc (NET) · Other
Cloudflare is scheduled to host an Investor Day on June 9, 2026; a >=5% price impact is estimated as the company provides strategic updates scheduled.
6/9/2026, 12:00:00 AM
Chipotle Mexican Grill Inc (CMG) · Other
Shareholders approved a 50-for-1 stock split at the annual meeting on June 6, 2026. This major corporate action is expected to have a high price impact as it confirms the historic split scheduled.
6/6/2026, 12:00:00 AM
Hewlett Packard Enterprise Co (HPE) · Earnings Release
Q2 2026 earnings release is scheduled.
6/2/2026, 12:00:00 AM
Marvell Technology Inc (MRVL) · Earnings Release
First quarter fiscal year 2027 earnings results are scheduled to be released on May 29, 2026. Market impact is estimated at >1% as earnings releases typically drive volatility scheduled.
5/29/2026, 12:00:00 AM
Analog Devices Inc (ADI) · Earnings Release
Analog Devices is expected to release its fiscal second quarter 2026 financial results around late May. The date is estimated based on previous reporting schedules and is scheduled.
5/28/2026, 12:00:00 AM
Costco Wholesale Corp (COST) · Earnings Release
Third quarter fiscal 2026 earnings release, estimated to have a moderate impact on the stock price upon release, scheduled.
5/28/2026, 12:00:00 AM